Your browser is no longer supported. Please, upgrade your browser.
MOTS Motus GI Holdings, Inc. daily Stock Chart
Motus GI Holdings, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own18.40% Shs Outstand15.13M Perf Week-11.99%
Market Cap71.11M Forward P/E- EPS next Y-0.90 Insider Trans- Shs Float13.18M Perf Month9.92%
Income-13.20M PEG- EPS next Q-0.29 Inst Own50.00% Short Float0.17% Perf Quarter-1.18%
Sales0.01M P/S10158.71 EPS this Y-159.90% Inst Trans- Short Ratio0.39 Perf Half Y-
Book/sh1.33 P/B3.53 EPS next Y7.90% ROA- Target Price7.00 Perf Year-
Cash/sh1.23 P/C3.82 EPS next 5Y- ROE- 52W Range3.75 - 7.85 Perf YTD7.31%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-40.13% Beta-
Dividend %- Quick Ratio12.30 Sales past 5Y- Gross Margin- 52W Low25.33% ATR0.39
Employees39 Current Ratio12.30 Sales Q/Q- Oper. Margin- RSI (14)52.44 Volatility8.28% 7.60%
OptionableNo Debt/Eq0.00 EPS Q/Q-268.60% Profit Margin- Rel Volume0.23 Prev Close4.55
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume56.81K Price4.70
Recom1.50 SMA202.31% SMA503.16% SMA2002.34% Volume13,174 Change3.30%
May-23-18 07:35AM  Motus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized Patients Business Wire
May-21-18 07:35AM  Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® System Business Wire -6.74%
May-15-18 07:35AM  Motus GI Reports 2018 First Quarter Financial Results and Provides Business Update Business Wire
May-10-18 08:05AM  Motus GI to Present Data at Digestive Disease Week® 2018 Showing Pure-Vu® System May Reduce Costs and Incidence of Colorectal Cancer Business Wire -5.79%
Apr-16-18 08:05AM  Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF Business Wire
Mar-29-18 07:05AM  Motus GI Announces 2017 Financial Results and Provides Business Outlook Business Wire
Mar-27-18 07:35AM  Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System Business Wire
Mar-20-18 08:05AM  Motus GI Announces Issuance of European Patent for the Pure-Vu® System Business Wire
Mar-13-18 08:35AM  Motus GI to Present at the Oppenheimer 28th Annual Healthcare Conference Business Wire
Feb-27-18 07:30AM  Motus GI Receives CE Mark Approval for the Pure-Vu® System Business Wire +5.13%
Feb-20-18 08:00AM  Motus GI Announces NASDAQ Closing Bell Ceremony Marketwired
Feb-16-18 04:05PM  Motus GI Announces Closing of Initial Public Offering Marketwired -6.98%
12:00PM  Motus GI Holdings, Inc. (Nasdaq: MOTS) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Feb-14-18 11:39AM  Motus shares slide 8% in trading debut MarketWatch
10:37AM  Medical device company Motus prices IPO at $5, low end of range MarketWatch
Motus GI Holdings, Inc., a medical technology company, focuses on the development and commercialization of the Pure-Vu System. Its Pure-Vu System is designed to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. Motus GI Holdings, Inc. is based in Fort Lauderdale, Florida.